EN DE
Watch Banvit Bandirma Vitaminli Yem Sanayi AS for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of Banvit Bandirma Vitaminli Yem Sanayi AS stock TRY 105, price TRY 111, that is 5.4% below the price, quality 31 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive TR · ISIN TRABANVT92A9

BB Banvit Bandirma Vitaminli Yem Sanayi AS logo Thin data Nov 16, 2026

Banvit Bandirma Vitaminli Yem Sanayi AS

BANVT · IS

The stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.

Get notified free when this changes
Low debt 
Fair value 105.05 TRY · Fairly valued 
Expensive Growth (revenue 5y +55.5 %/yr in TRY) 
Revenue last quarter 10% below a year ago. 
Quality 31/100 
Falling price (downtrend) 
Loss-making · -10.7% net margin (TTM) 
Negative free cash flow 
Trails peers (3/11) 
Narrow moat 7/100 · thin data
Thin data 
Estimate⚠ Small free float
Watch Banvit Bandirma Vitaminli Yem Sanayi AS for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

437.50 TRY 64.00 TRY Fair Value 105.05 TRY Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

60‑month range 64.00 TRY – 437.50 TRY · fair‑value band 78.79 TRY – 131.31 TRY · the 111.00 TRY price screens above the 105.05 TRY fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 16, 2026.

Follow Banvit Bandirma Vitaminli Yem Sanayi AS in your weekly email

Every Wednesday you see whether Banvit Bandirma Vitaminli Yem Sanayi AS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi operates as a food company in Turkey. It engages in production, processing, sales, and marketing of feed, breeder eggs, day-old broiler chicks, live broilers, broiler meat, and further processed products. The company also exports its products.

Show moreShow less

It distributes its products through the branches and dealers. The company was incorporated in 1968 and is headquartered in Balikesir, Turkey. Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi is a subsidiary of BRF GmbH.

Stock analysis

Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT) currently trades at 111.00 TRY, while our estimate is 105.05 TRY, so the stock looks roughly fairly valued today (gap 5.7%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: 78.79 TRY (bear) to 131.31 TRY (bull), the price of 111.00 TRY sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 31/100 (below-average quality), in the Consumer Defensive sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Banvit Bandirma Vitaminli Yem Sanayi AS reported revenue of 33.5B TRY in FY2025 versus 5.3B TRY in FY2021, a compound +58.4%/yr. Reported net income was −3.1B TRY in FY2025.

Key figures

Market cap 11.1B TRY (≈ $220M) Micro · P/S ratio 0.37 · EPS (TTM) −33.12 TRY · Net margin −10.7% · Return on equity −27.1% · Return on assets (EBIT) 6.7% (5-year average) · Operating margin −1.4% · Revenue (TTM) 30.2B TRY.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 7 out of 100 (low confidence).

What moves the price

The share trades about 40% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 0% fair-value upside, at −5%, BANVT screens richer than that median.

Fair Value

Bear 78.79 TRY Fair Value 105.05 TRY Bull 131.31 TRY
Price 111.00 TRY · Downside -5.4%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 31/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 21
How much profit the company makes from its sales and capital
Quality Growth 0
Are margins and returns getting better?
Cashflow 3
Do the profits arrive as real cash?
Financial strength 71
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Low Volatility 81
How calm the share price moves, does not count
Price momentum 10
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 32/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−18.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+45.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+55.5%
Start year 2020 (pandemic). Over 10 years: +32.5% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+23.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1.9% (2020) → −8.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch BANVT, get fair value alerts →

Compare Banvit Bandirma Vitaminli Yem Sanayi AS with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 663 stocks

Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 31 · Bottom 25%
Fair Value upside −5.4% · Below median
Profitability
Return on assets −12.4% · Bottom 25%
Net margin (12 months) −10.7% · Bottom 25%
Operating margin (12 months) −1.4% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −10.0% · Bottom 25%
Balance sheet
Debt / equity 0.00× · Lowest 25%

Valuation Multiplesvs Packaged Foods median · lower = cheaper

P/B 1.00× · Cheaper than median
P/S (12 months) 0.37× · Cheaper than median
PEG 1.91× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)26 · sector 34
FUTURE (revenue growth)0 · sector 26
PAST (return on equity)0 · sector 31
HEALTH (low debt)100 · sector 96
DIVIDEND (yield)0 · sector 54

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wilmar International Limited F34 2.90 SGD 4.94 SGD +70% vs BANVT
Inner Mongolia Yili Industrial Group 600887 ¥32.20 ¥41.84 +30% vs BANVT
The Kraft Heinz Company KHC $25.07 $29.20 +16% vs BANVT
Foshan Haitian Flavouring and Food Company 603288 ¥35.76 ¥38.07 +6% vs BANVT
General Mills, Inc GIS $35.24 $35.30 +0% vs BANVT
Danone S.A BN €70.66 €50.65 −28% vs BANVT
Nestlé S.A NESN CHF 88.12 CHF 59.51 −32% vs BANVT
Kerry Group KRZ €101.80 €60.33 −41% vs BANVT
Nestlé India Limited NESTLEIND ₹1,297 ₹724.74 −44% vs BANVT
Yihai Kerry Arawana Holdings 300999 ¥25.32 ¥12.21 −52% vs BANVT

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Banvit Bandirma Vitaminli Yem Sanayi AS: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Banvit Bandirma Vitaminli Yem Sanayi AS Fair Value". https://www.fairvalue-calculator.com/stock/BANVT

Frequently asked questions

Is Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT) overvalued or undervalued?
As of Nov 16, 2026, our estimate of fair value is 105.05 TRY versus a price of 111.00 TRY, about 5% lower (fairly valued).
What is the fair value of BANVT?
Our estimate for Banvit Bandirma Vitaminli Yem Sanayi AS is 105.05 TRY (as of Nov 16, 2026), built from audited fundamentals. The current price: 111.00 TRY.
What is the quality score of BANVT?
Banvit Bandirma Vitaminli Yem Sanayi AS has a Quality Score of 31/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Our calculated price target is the estimate of 105.05 TRY (as of Nov 16, 2026). Cautious scenario 78.79 TRY, optimistic scenario 131.31 TRY. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Banvit Bandirma Vitaminli Yem Sanayi AS stock forecast for 2026?
Our estimate puts fair value at 105.05 TRY, about 5% lower versus a price of 111.00 TRY (fairly valued). Cautious scenario 78.79 TRY, optimistic scenario 131.31 TRY. The calculation is refreshed regularly with new filings.
What is the revenue of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Banvit Bandirma Vitaminli Yem Sanayi AS reported trailing-twelve-month revenue of about 30.2B TRY (latest available figure, as of Nov 16, 2026).
What is the intrinsic value of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Banvit Bandirma Vitaminli Yem Sanayi AS it is 105.05 TRY per share (as of Nov 16, 2026), against a price of 111.00 TRY.
Is Banvit Bandirma Vitaminli Yem Sanayi AS stock overvalued or undervalued in 2026?
As of Nov 16, 2026, BANVT trades above its calculated fair value: price 111.00 TRY, fair value 105.05 TRY, a gap of about −5% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BANVT?
No. The price is what the market pays today (111.00 TRY); the fair value is what the company's own numbers justify (105.05 TRY). For Banvit Bandirma Vitaminli Yem Sanayi AS the two are 5.95 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is Banvit Bandirma Vitaminli Yem Sanayi AS worth?
The market values Banvit Bandirma Vitaminli Yem Sanayi AS at about 11.1B TRY (market capitalisation, as of Nov 16, 2026). Per share that is 111.00 TRY; our models calculate a fair value of 105.05 TRY per share.
What do the bullish and bearish scenarios say about BANVT?
Our models span a range for Banvit Bandirma Vitaminli Yem Sanayi AS: cautious scenario 78.79 TRY, base 105.05 TRY, optimistic 131.31 TRY per share (as of Nov 16, 2026, price 111.00 TRY). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of BANVT?
The PEG ratio of Banvit Bandirma Vitaminli Yem Sanayi AS is 1.91 (P/E divided by earnings growth, as of Nov 16, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Balance-sheet figures for Banvit Bandirma Vitaminli Yem Sanayi AS (as of Nov 16, 2026): return on equity −27.1%, debt of 0.00 per unit of equity. They feed the Quality Score of 31/100, which measures business quality independently of the share price.
How far is BANVT from its 52-week high?
Banvit Bandirma Vitaminli Yem Sanayi AS trades at 111.00 TRY, about 40% below its 52-week high of 184.90 TRY and 2% above the low of 108.60 TRY (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of 105.05 TRY is for.
Which stocks are comparable to Banvit Bandirma Vitaminli Yem Sanayi AS?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, Inner Mongolia Yili Industrial Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Banvit Bandirma Vitaminli Yem Sanayi AS stock attractive at the current price?
The data as of Nov 16, 2026: price 111.00 TRY, calculated fair value 105.05 TRY (−5%), Quality Score 31/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Banvit Bandirma Vitaminli Yem Sanayi AS itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
The closing price on Nov 16, 2026 was 111.00 TRY. Our estimate is 105.05 TRY, about 5% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Banvit Bandirma Vitaminli Yem Sanayi AS right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Banvit Bandirma Vitaminli Yem Sanayi AS

How large is the market capitalisation of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
The market capitalisation of Banvit Bandirma Vitaminli Yem Sanayi AS is 11.1B TRY (≈ $220M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
The price-to-sales ratio of Banvit Bandirma Vitaminli Yem Sanayi AS is 0.37 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Earnings per share at Banvit Bandirma Vitaminli Yem Sanayi AS are −33.12 TRY. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
The net margin of Banvit Bandirma Vitaminli Yem Sanayi AS is −10.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
The return on equity (ROE) of Banvit Bandirma Vitaminli Yem Sanayi AS is −27.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
On an EBIT basis the return on assets of Banvit Bandirma Vitaminli Yem Sanayi AS is 6.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
The operating margin of Banvit Bandirma Vitaminli Yem Sanayi AS is −1.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Revenue at Banvit Bandirma Vitaminli Yem Sanayi AS is down 10.0% versus a year earlier (3y avg +45.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT)?
Earnings per share at Banvit Bandirma Vitaminli Yem Sanayi AS are growing 64.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT) generate?
The free cash flow of Banvit Bandirma Vitaminli Yem Sanayi AS is −23.4B TRY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Banvit Bandirma Vitaminli Yem Sanayi AS (BANVT) carry?
The net debt of Banvit Bandirma Vitaminli Yem Sanayi AS is 209M TRY (fiscal year 2023). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Banvit Bandirma Vitaminli Yem Sanayi AS in the live analysis

One click puts Banvit Bandirma Vitaminli Yem Sanayi AS on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.